Loading...

FITC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_FITC_090707
Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
  • BM8_FITC_090707
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
123107 50 µg $65
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123108 500 µg $185
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  2. Vasanthakumar A, et al. 2020. Nature. 579:581. PubMed
  3. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  4. Li F, et al. 2022. Mediators Inflamm. 2022:5782922. PubMed
  5. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  6. Liu J, et al. 2019. Immunity. 50:600. PubMed
  7. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  8. Wang L, et al. 2008. Cancer Res. 68:5639. PubMed
  9. Jiang L, et al. 2013. Mol Immunol. 54:14. PubMed
  10. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  11. Marcil A, et al. 2008. Infect Immun. 76:4345. PubMed
  12. Kimura H, et al. 2017. J Immunol. 10.4049/jimmunol.1601798. PubMed
  13. Zheng M, et al. 2016. Sci Rep. 6:28729. PubMed
  14. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  15. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  16. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  17. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  18. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  19. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  20. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  21. Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed
  22. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  23. Chauhan A, et al. 2020. Nat Commun. 11:1939. PubMed
  24. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  25. Gu T, et al. 2021. Front Immunol. 11:621441. PubMed
  26. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  27. Mouton AJ, et al. 2018. Basic Res Cardiol. 113:26:00. PubMed
  28. Lee Y, et al. 2017. PLoS One.. 10.1371/journal.pone.0183028. PubMed
  29. Stubelius A, et al. 2017. Immunobiology. 10.1016/j.imbio.2017.05.007. PubMed
  30. Alvarez M, et al. 2020. Cancers (Basel). 12:. PubMed
  31. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  32. Wang Y, et al. 2020. J Immunol. 205:2905. PubMed
  33. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  34. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  35. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  36. Qiu X, et al. 2019. Theranostics. 9:2618. PubMed
  37. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  38. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  39. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  40. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  41. Kedage V, et al. 2022. MAbs. 14:2040083. PubMed
  42. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  43. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  44. Dichtl S, et al. 2021. Sci Adv. 7: . PubMed
  45. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  46. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  47. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  48. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  49. Xiao P, et al. 2021. JCI Insight. 6:. PubMed
  50. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  51. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  52. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  53. Zhang Y, et al. 2022. Nat Commun. 13:4553. PubMed
  54. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  55. Nakazeki F, et al. 2018. Sci Rep. 8:8553. PubMed
  56. Barger SR, et al. 2019. Nat Commun. 10:1249. PubMed
  57. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  58. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  59. García-Bonilla M, et al. 2020. Stem Cell Res Ther. 11:121. PubMed
  60. Niss K, et al. 2020. Cell Reports. 31(11):107763. PubMed
  61. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  62. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  63. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  64. Yu H, et al. 2022. J Orthop Surg Res. 17:232. PubMed
  65. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  66. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  67. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  68. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  69. Zhao X, et al. 2014. J Biol Chem. 289:30052. PubMed
  70. Suo J, et al. 2014. J Leukoc Biol. 96:133. PubMed
  71. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  72. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  73. Wang Y, et al. 2021. EMBO J. 40:e105543. PubMed
  74. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  75. Wu W, et al. 2018. J Am Soc Nephrol. 29:168. PubMed
  76. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  77. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  78. Odkhuu E, et al. 2014. Innate Immunity. 21:194. PubMed
  79. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  80. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  81. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  82. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  83. Wang H, et al. 2022. J Nanobiotechnology. 20:445. PubMed
  84. Wang Y, et al. 2022. Cell Death Dis. 13:748. PubMed
  85. Wu Y, et al. 2021. PLoS Negl Trop Dis. 15:e0010050. PubMed
  86. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  87. Cai C, et al. 2021. Sci Rep. 11:13386. PubMed
  88. Moon H, et al. 2020. Nat Commun. 4.270138889. PubMed
  89. Wan X, et al. 2018. Nature. 560:107. PubMed
  90. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  91. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  92. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  93. Irie Y, et al. 2017. J Neuroimmune Pharmacol. 10.1007/s11481-017-9757-2. PubMed
  94. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  95. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  96. Miki Y, et al. 2013. J Exp Med. 210:1217. PubMed
  97. Linde N, et al. 2012. PLoS One. 7:e40058. PubMed
  98. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  99. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  100. Qin W, et al. 2021. FASEB J. 35:e21599. PubMed
  101. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  102. Matsumoto K, et al. 2017. PLoS One. 12(6):e0175406. PubMed
  103. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  104. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  105. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  106. Kasahara D, et al. 2012. J Immunol. 188:4558. PubMed
  107. Artz A, Butz S, Vestweber D 2016. Am J Physiol Renal Physiol. 311: F176 - F181. PubMed
  108. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  109. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  110. Deng G, et al. 2010. J Immunol. 184:7154. PubMed
  111. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  112. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  113. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  114. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  115. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  116. Parayath NN, et al. 2020. Nat Commun. 4.680555556. PubMed
  117. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  118. Torres I, et al. 2014. Infect Immun . 82:4689. PubMed
  119. Taye B, et al. 2017. BMC Genomics . 10.1186/s12864-017-3803-6. PubMed
  120. Wang Y et al. 2017. Cell. 171(2):331-345 . PubMed
  121. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  122. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  123. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  124. Howard ZM, et al. 2022. JCI Insight. 7:. PubMed
  125. Miki Y, et al. 2022. JCI Insight. 7:. PubMed
  126. Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed
  127. Raoof R, et al. 2021. J Neurosci. 41:8249. PubMed
  128. Wang X, et al. 2022. J Biol Chem. 298:101561. PubMed
  129. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  130. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  131. Fukushima K, et al. 2020. Immunity. 52(3):542-556. PubMed
  132. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  133. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  134. Du H, et al. 2017. Nat Commun. 10.1038/s41467-017-00522-7. PubMed
  135. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  136. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  137. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  138. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  139. Drori A, et al. 2014. PLoS One. 9:110942. PubMed
  140. Quick M, et al. 2012. Am J Physiol Regul Integr Comp Physiol. 303:580. PubMed
  141. Deng Q, et al. 2021. Gut Microbes. 13:1. PubMed
  142. Glasenapp A, et al. 2021. Circ Res. 129:369. PubMed
  143. Zheng X, et al. 2020. Int J Cancer. 146:1730. PubMed
  144. Dongsheng Z, et al. 2017. Inflammation. 10.1007/s10753-017-0619-0. PubMed
  145. Di G, et al. 2017. Invest Ophthalmol Vis Sci. 10.1167/iovs.17-21506. PubMed
  146. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  147. Osorio K, et al. 2011. J Cell Biol. 193:235. PubMed
  148. Chen Z, et al. 2016. PLoS One. 11: 0146681. PubMed
  149. Mothes B, et al. 2016. PLoS One. 11: 0159310. PubMed
  150. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  151. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  152. Lv JJ, et al. 2021. Front Cell Dev Biol. 8:609090. PubMed
  153. Yan T, et al. 2021. Toxicological Sciences. 181(2):273-284. PubMed
  154. Lu Q, et al. 2022. Biomed Res Int. 2022:9427076. PubMed
  155. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  156. Howard ZM, et al. 2021. Am J Pathol. 191:730. PubMed
  157. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  158. Zhao H, et al. 2022. Commun Biol. 5:74. PubMed
  159. Lee SA, et al. 2021. Cells. 10:. PubMed
  160. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  161. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  162. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  163. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  164. van Aalst S, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.02.005. PubMed
  165. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  166. Morein D, et al. 2021. Cells. 10: . PubMed
  167. Sakurai Y, et al. 2021. Pharmaceutics. 13:. PubMed
  168. Zhang F, et al. 2021. J Immunol Res. 2021:5521051. PubMed
  169. Liu C, et al. 2022. Cell Death Discov. 8:269. PubMed
  170. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  171. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  172. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  173. Lancaster GI et al. 2018. Cell metabolism. 27(5):1096-1110 . PubMed
  174. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  175. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  176. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  177. Vazquez-Lombardi R, et al. 2017. Nat Commun. 8:15373. PubMed
  178. Elias I, et al. 2012. Diabetes. 61:1801. PubMed
  179. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  180. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  181. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  182. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  183. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  184. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  185. Kwon H, Kim S 2016. Cell Death Dis. 7:22285. PubMed
  186. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  187. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  188. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  189. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  190. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  191. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  192. Bhatia S, et al. 2019. Cancer Res. 79:2722. PubMed
  193. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  194. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  195. Bringmann G, et al. 2013. Antimicrob Agents Chemother. 57:3003. PubMed
  196. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  197. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  198. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  199. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  200. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  201. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  202. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  203. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  204. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  205. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  206. Wegiel B, et al. 2014. Cell Death Dis. 5:1139. PubMed
  207. Richardson M, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
RRID
AB_893500 (BioLegend Cat. No. 123107)
AB_893502 (BioLegend Cat. No. 123108)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Go To Top Version: 2    Revision Date: 10/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account